LPL Financial »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by LPL Financial

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by LPL Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $37k 31k 1.19

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr Series Trust St Str P500etf (SPYM)
Spdr Series Trust ST STR P500GRW (SPYG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Capital Group Dividend Value Shs Creat Unit (CGDV)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Us Treas Bd Etf (GOVT)

View all positions for LPL Financial

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Steelhead Partners
Bnp Paribas Arbitrage, Snc
Alberta Investment Management Corporation
DeepCurrents Investment Group
State Street Corporation
Bank of America Corporation
FMR
MacKay Shields
Manufacturers Life Insurance Company
Universal- Beteiligungs- und Servicegesellschaft mbH
Bnp Paribas Investment Partners
CSS
Ameriprise Financial
BlackRock
Toronto-Dominion Bank

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1